Page 14 - Access Bio News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Biden to mandate vaccination for all federal workers and contractors, with no testing alternative
hotair.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from hotair.com Daily Mail and Mail on Sunday newspapers.
NJ Workers Filed Thousands Of COVID-19 Complaints Against Their Employers Here Are The Worst Offenders
gothamist.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from gothamist.com Daily Mail and Mail on Sunday newspapers.
At-Home COVID-19 Antigen Tests: What You Should Know
nytimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from nytimes.com Daily Mail and Mail on Sunday newspapers.
Assessment of CareStart G6PD rapid diagnostic test and CareStart G6PD biosensor in Mauritania | Infectious Diseases of Poverty
biomedcentral.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biomedcentral.com Daily Mail and Mail on Sunday newspapers.
The
Atomo Diagnostics Ltd (ASX: AT1) share price has rocketed in opening trade today after the medical device company released its fourth-quarter results to the ASX.
At the time of writing, the Atomo share price is trading 9.30% higher at 23.5 cents apiece.
How did Atomo perform for the quarter?
The Atomo share price is soaring after the company reported a robust performance during the fourth quarter.
For the period ending 30 June, Atomo recorded cash receipts from customers of $717,000, bringing the full-year to $8.01 million. It’s worth noting that shortly after the close of Q4 FY21, a further $750,000 was received.
Sales represented a total of $6.7 million for the 2021 financial year, up by 25% when compared to FY20 ($5.4 million).